Endoscope reprocessing devices are used in the healthcare settings for the reprocessing procedures of the endoscopes. The endoscope reprocessing devices are used to decontaminate the instruments and devices such as duodenoscopes, endoscope accessories, and others. Endoscope reprocessing devices are Class II devices cleared through the premarket notification by the Food and Drug Administration (FDA). The devices are designed to inhibit microorganisms in or on reusable endoscopes by exposing their outside surfaces and interior channels to chemical solutions. Moreover, the endoscope reprocessing devices reduce staff exposure hazards associated with aldehyde-based solutions, thus granting major safety advantage for the adoption and usage of endoscope reprocessing devices.

Restraints of the Global Automated Endoscope Reprocessors Market

Major factors hampering the growth of the automated endoscope reprocessors market during the forecast period constitutes of lack of proper guidelines regarding proper selection and usage of automated endoscope reprocessors.

Key features of the study

• This report provides in-depth analysis of the global automated endoscope reprocessors market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2019–2027), considering 2018, as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
• It profiles leading players in the global automated endoscope reprocessors market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
• Key companies covered as a part of this study include STERIS Plc., Olympus Corporation, Laboratory Anios, Hoya Corporation, Getinge AB, Metull Zug AG, Steelco S.p.A., Cantel Medical Corp., Advanced Sterilization Products, Custom Ultrasonics, and Johnson & Johnson
• Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
• The global automated endoscope reprocessor’s market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Market Segmentation

• By Product Type
  • Single Basin AER
  • Dual Basin AER
• By Modality
  • Standalone AER
  • Bench top AER
• By End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Clinics
• By Regions
  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Middle East
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • North Africa
    • Central Africa
    • South Africa
• Key Players
  • STERIS Plc.
  • Olympus Corporation
  • Laboratory Anios
  • Hoya Corporation
  • Getinge AB
  • Metull Zug AG
  • Steelco S.p.A.
  • Cantel Medical Corp.
  • Advanced Sterilization Products
  • Custom Ultrasonics
  • Johnson & Johnson